Epithelial-Mesenchymal Transition, human (Scheel, 2011)
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
FOXO4 | hg38_v1_chrX_+_71095838_71095860 | -0.38 | 3.6e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr1_-_56579555 Show fit | 1.75 |
ENST00000371250.4
|
phospholipid phosphatase 3 |
|
chr9_-_92424427 Show fit | 1.52 |
ENST00000375550.5
|
osteomodulin |
|
chr11_+_114060204 Show fit | 1.48 |
ENST00000683318.1
|
zinc finger and BTB domain containing 16 |
|
chr10_+_69088096 Show fit | 1.16 |
ENST00000242465.4
|
serglycin |
|
chr14_-_59630582 Show fit | 1.13 |
ENST00000395090.5
|
reticulon 1 |
|
chr6_-_152168291 Show fit | 1.10 |
ENST00000354674.5
|
spectrin repeat containing nuclear envelope protein 1 |
|
chr6_-_152168349 Show fit | 1.09 |
ENST00000539504.5
|
spectrin repeat containing nuclear envelope protein 1 |
|
chr4_+_123399488 Show fit | 0.84 |
ENST00000394339.2
|
sprouty RTK signaling antagonist 1 |
|
chr4_-_158159657 Show fit | 0.71 |
ENST00000590648.5
|
golgi associated kinase 1B |
|
chr1_-_145910031 Show fit | 0.68 |
ENST00000369304.8
|
integrin subunit alpha 10 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.2 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.2 | 1.7 | GO:0042078 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.1 | 1.7 | GO:0008354 | germ cell migration(GO:0008354) |
0.5 | 1.5 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
0.1 | 1.5 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.4 | 1.2 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.2 | 1.2 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 1.1 | GO:0045600 | positive regulation of fat cell differentiation(GO:0045600) |
0.1 | 0.9 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.2 | 0.8 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.2 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 1.8 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 1.5 | GO:0097386 | glial cell projection(GO:0097386) |
0.3 | 1.3 | GO:0034680 | integrin alpha10-beta1 complex(GO:0034680) |
0.0 | 1.0 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 0.6 | GO:0010369 | chromocenter(GO:0010369) |
0.1 | 0.4 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 0.4 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
0.0 | 0.4 | GO:0030478 | actin cap(GO:0030478) |
0.0 | 0.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 2.1 | GO:0005521 | lamin binding(GO:0005521) |
0.3 | 1.7 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.5 | 1.5 | GO:0016880 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 1.5 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 1.3 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
0.2 | 0.6 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.2 | 0.6 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.1 | 0.6 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.1 | 0.6 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 0.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.0 | 1.3 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.6 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.6 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 0.4 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.2 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 1.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 1.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.9 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 0.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.6 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.0 | 0.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.0 | 0.5 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.0 | 0.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.4 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |